Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

医学 不利影响 内科学 临床试验 肿瘤科 荟萃分析
作者
Yucai Wang,Shouhao Zhou,Fang Yang,Xinyue Qi,Xin Wang,Xiaoxiang Guan,Chan Shen,Narjust Duma,Jesus Vera Aguilera,Ashish V. Chintakuntlawar,Katharine A. Price,Julian R. Molina,Lance C. Pagliaro,Þorvarður R. Hálfdánarson,Axel Grothey,Svetomir N. Markovic,Grzegorz S. Nowakowski,Stephen M. Ansell,Michael Wang
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:5 (7): 1008-1008 被引量:688
标识
DOI:10.1001/jamaoncol.2019.0393
摘要

Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have been increasingly used in cancer therapy. Understanding the treatment-related adverse events of these drugs is critical for clinical practice.To evaluate the incidences of treatment-related adverse events of PD-1 and PD-L1 inhibitors and the differences between different drugs and cancer types.PubMed, Web of Science, Embase, and Scopus were searched from October 1, 2017, through December 15, 2018.Published clinical trials on single-agent PD-1 and PD-L1 inhibitors with tabulated data on treatment-related adverse events were included.Trial name, phase, cancer type, PD-1 and PD-L1 inhibitor used, dose escalation, dosing schedule, number of patients, number of all adverse events, and criteria for adverse event reporting data were extracted from each included study, and bayesian multilevel regression models were applied for data analysis.Incidences of treatment-related adverse events and differences between different drugs and cancer types.This systematic review and meta-analysis included 125 clinical trials involving 20 128 patients; 12 277 (66.0%) of 18 610 patients from 106 studies developed at least 1 adverse event of any grade (severity), and 2627 (14.0%) of 18 715 patients from 110 studies developed at least 1 adverse event of grade 3 or higher severity. The most common all-grade adverse events were fatigue (18.26%; 95% CI, 16.49%-20.11%), pruritus (10.61%; 95% CI, 9.46%-11.83%), and diarrhea (9.47%; 95% CI, 8.43%-10.58%). The most common grade 3 or higher adverse events were fatigue (0.89%; 95% CI, 0.69%-1.14%), anemia (0.78%; 95% CI, 0.59%-1.02%), and aspartate aminotransferase increase (0.75%; 95% CI, 0.56%-0.99%). Hypothyroidism (6.07%; 95% CI, 5.35%-6.85%) and hyperthyroidism (2.82%; 95% CI, 2.40%-3.29%) were the most frequent all-grade endocrine immune-related adverse events. Nivolumab was associated with higher mean incidences of all-grade adverse events compared with pembrolizumab (odds ratio [OR], 1.28; 95% CI, 0.97-1.79) and grade 3 or higher adverse events (OR, 1.30; 95% CI, 0.89-2.00). PD-1 inhibitors were associated with a higher mean incidence of grade 3 or higher adverse events compared with PD-L1 inhibitors (OR, 1.58; 95% CI, 1.00-2.54).Different PD-1 and PD-L1 inhibitors appear to have varying treatment-related adverse events; a comprehensive summary of the incidences of treatment-related adverse events in clinical trials provides an important guide for clinicians.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小白完成签到,获得积分10
1秒前
科隆龙完成签到,获得积分10
5秒前
DAYTOY完成签到,获得积分10
7秒前
zx完成签到,获得积分20
8秒前
在水一方应助方法采纳,获得10
8秒前
Ava应助孙成成采纳,获得30
9秒前
凡迪亚比应助lena采纳,获得10
12秒前
13秒前
13秒前
香蕉觅云应助zcy采纳,获得10
15秒前
NexusExplorer应助科研通管家采纳,获得10
16秒前
田様应助科研通管家采纳,获得10
16秒前
未命名应助科研通管家采纳,获得20
16秒前
lant0932应助科研通管家采纳,获得10
16秒前
Lyla应助科研通管家采纳,获得10
16秒前
俏皮诺言发布了新的文献求助10
16秒前
JamesPei应助科研通管家采纳,获得10
17秒前
无花果应助科研通管家采纳,获得10
17秒前
传奇3应助科研通管家采纳,获得10
17秒前
AGuang应助科研通管家采纳,获得10
17秒前
Ava应助科研通管家采纳,获得10
17秒前
大模型应助科研通管家采纳,获得10
17秒前
领导范儿应助科研通管家采纳,获得10
17秒前
桐桐应助科研通管家采纳,获得30
17秒前
逸之狐应助科研通管家采纳,获得20
17秒前
香蕉觅云应助科研通管家采纳,获得10
17秒前
18秒前
22秒前
seal发布了新的文献求助10
24秒前
myduty完成签到 ,获得积分10
24秒前
123完成签到,获得积分10
24秒前
25秒前
25秒前
老实雁蓉完成签到,获得积分10
27秒前
27秒前
Brian发布了新的文献求助10
27秒前
27秒前
27秒前
寒江雪举报起名求助涉嫌违规
29秒前
洞幺拐发布了新的文献求助10
29秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Christian Women in Chinese Society: The Anglican Story 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961083
求助须知:如何正确求助?哪些是违规求助? 3507362
关于积分的说明 11135734
捐赠科研通 3239863
什么是DOI,文献DOI怎么找? 1790434
邀请新用户注册赠送积分活动 872400
科研通“疑难数据库(出版商)”最低求助积分说明 803150